Іздеу

Шығарылым
Атауы
Авторлар
Therapeutic use of amaranth oil: current trends and prospects of use
Mubarakshina O., Batishcheva G., Zhdanova O., Volynkina A., Grechushkina I.
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
Latent autoimmune diabetes in adults: current concepts of risk factors, diagnosis, and therapy
Druk I., Safronova S., Kulebakina K.
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.
Monogennye formy sakharnogo diabeta
Zubkova N., Tikhonovich Y., Tyul'pakov A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.
Adherence to modern technologies of glycemic management in diabetic patients
Chernikova N., Prokhorova K., Gancho I.
Diabetes mellitus and periodontal diseases: together or in parallel?
Trukhan D., Sulimov A., Trukhan L.
Effects of ipragliflozin in patients with type 2 diabetes mellitus, arterial hypertension and left ventricular diastolic dysfunction in a short-term prospective study
Safronova S., Druk I., Kanunnikova O., Korennova O., Podolnaya S., Klepatskaya T., Kalinina I.
Intensification of diabetes therapy using insulin degludec. A series of atypical clinical cases
Smirnova E.
Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors
Zhurtova I., Aramisova L., Abdul Moati H., Arkhestova D., Khachmakhova E.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
Glucometer with a mobile application as a system for remote control of diabetes
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M., Golubeva Y.
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N., Martirosyan N., Valeeva F.
Application of the diabetes screening questionnaire in patients with psoriasis
Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.
Obesity: an invisible disease
Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N., Knyshenko O., Ivanova L.
Gestational diabetes mellitus: prevention of reproductive loss
Glavnova O., Shelygin M., Salukhova A.
Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus
Demicheva T.
Modern topical treatment of psoriasis in diabetic patients
Lykova S., Nemchaninova O., Svechnikova E., Morzhanayeva M.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E., Solovyova I.
Insulin detemir and its place in the diabetes treatment: results of 15-year use
Girsh Y.
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y., Zanozin A., Zanozina O., Runov G.
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E., Antsiferov M.
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N., Terekhova A.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E., Tyulganova V.
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.
SVYaZ' MIKROBNOGO PEYZAZhA KIShEChNIKA S METABOLIChESKIM SINDROMOM
Plotnikova E., Krasnov O.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N., Ivanova L., Abaeva F.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N., Shamkhalova M.
Ispol'zovanie preparatov, proizvedennykh po novym tekhnologiyam, v lechenii nealkogol'nogo steatogepatita
Kazyulin A., Babina S.
VOZMOZhNOSTI DIBIKORA V KORREKTsII METABOLIChESKIKh I SOSUDISTYKh NARUShENIY U BOL'NYKh KhRONIChESKOY SERDEChNOY NEDOSTATOChNOST'Yu I SAKhARNYM DIABETOM 2 TIPA
Statsenko M., Vinnikova A., Shilina N., Ronskaya A.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A., Tertychnaya E.
Metabolicheskiy sindrom u bol'nykh sakharnym diabetom i ego korrektsiya preparatami tioktovoy kisloty
Kurnikova I.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L., Sorokin M.
Rol' taurina i ego defitsita v organizme cheloveka i zhivotnykh
Antsiferov M.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A., Valitov B., Chernikova N., Antsiferov M.
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
New possibilities for diabetic peripheral neuropathy treatment
Komelyagina E., Antsiferov M., Komelyagina E., Antsiferov M.
SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM
Ametov A., Karpova E.
MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY
Demidova I., Gorokhova T.
Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus
Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.
Blood lipid profile in patients with obesity and type 2 diabetes mellitus and without type 2 diabetes mellitus before and after bariatric surgery
Mozgunova V., Volkova A., Semikova G., Khalimov Y., Vasilevsky D., Balandov S., Anisimova K.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
Kurnikova I., Chekalina M., Ualikhanova A.
Deintensification of insulin therapy in elderly patients with type 2 diabetes mellitus: impact on glycemic control and risk of hypoglycemia
Glinkina I., Oderiy A., Galkina A., Berdygylydzhova G., Fadeev V.
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study
Farmanov A., Bublik E., Vinogradskaya O., Udovichenko O., Zilov A., Ryzhkova E., Egorov V., Fadeev V., Deunezheva S., Zhivov A., Tobianskaya I.
Modern technologies in diabetes management
Koteshkova O., Antsiferov M., Antsiferova D., Demidov N.
Sulodexide: meta-analysis of the treatment of diabetic nephropathy and literature review
Novikova M., Koteshkova O., Antsiferov M.
The effectiveness of the use of natural mineral water “Donat” in the complex therapy of lipid and carbohydrate metabolism disorders
Mubarakshina O., Elizarova I., Cherenkova O.
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)
Smirnova E.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N., Baranova N., Fedin A.
Cranial neuropathy as a complication of diabetes mellitus
Maksimova M., Stepanchenko O.
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Antsiferov M., Demidov N.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L., Verbovoy A.
Diabetic autonomic neuropathy: problems of diagnosis and therapy
Kurnikova I., Yurovsky A.
Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure
Demidova T., Titova V.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y., Martynyuk M.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
Verbovoy A., Sharonova L., Pashentseva A., Tsanava I.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A., Podachina S., Sviridova M.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
Kombinirovannaya tsitostaticheskaya i angioprotektivnaya terapiya bol'nykh psoriazom
Bakulev A., Utts S., Shtoda Y.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A., Verbovoy A.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
Sakharnyy diabet i osteoporoz. Analiz kombinirovannogo podkhoda k lecheniyu
Doskina E.
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N., Kuzina I.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E., Danilova T.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E., Rashid M., Antsiferov M.
Antiagregantnaya terapiya u patsientov s sakharnym diabetom, perenesshikh mozgovoy insul't
Matkevich E., Grapov D., Maksimov M.
Znachenie antioksidantnoy terapii v lechenii diabeticheskoy polinevropatii
Galstyan K.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A., Kulidzhanyan N., Shurupova I., Trifonova T., Antsiferov M.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A., Baturova V., Pogromov A., Yu Baturova V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G., Azimova Y., Tabeeva G., Azimova Y.
Advance - movement forward
Petunina N., Petunina N.
OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI
Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.
Нәтижелер 381 - 1/100 1 2 3 4 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>